Avecho and Sandoz Sign Exclusive CBD Licensing Agreement for Insomnia Treatment in Australia Avecho Biotechnology and Sandoz have entered an exclusive deal to develop and commercialize a CBD capsule for insomnia treatment in Australia.

Avecho and Sandoz Sign Exclusive CBD Licensing Agreement for Insomnia Treatment in Australia #Australia #Melbourne #CBD #Avecho #Sandoz

Avecho and Sandoz Expanding Collaboration with Exclusive CBD Licensing Agreement in Australia Avecho and Sandoz have established a decade-long partnership to develop a CBD capsule for treating insomnia in Australia, aiming for a lucrative market.

Avecho and Sandoz Expanding Collaboration with Exclusive CBD Licensing Agreement in Australia #Australia #Melbourne #CBD #Avecho #Sandoz

Avecho and Sandoz Sign Landmark CBD Development Agreement for Insomnia Treatment in Australia Avecho and Sandoz have formed an exclusive agreement to develop CBD capsules aimed at treating insomnia, with market potential exceeding $125 million.

Avecho and Sandoz Sign Landmark CBD Development Agreement for Insomnia Treatment in Australia #Australia #Melbourne #CBD #Avecho #Sandoz

Avecho and Sandoz Join Forces to Revolutionize CBD Therapy for Insomnia in Australia Avecho has signed a significant agreement with Sandoz to develop and commercialize CBD capsules for insomnia treatment in Australia, aiming for market success.

Avecho and Sandoz Join Forces to Revolutionize CBD Therapy for Insomnia in Australia #Australia #Melbourne #Avecho #Sandoz #CBD_Therapy

Avecho and Sandoz Announce Exclusive Ten-Year CBD Partnership for Insomnia Treatment in Australia Avecho Biotechnology and Sandoz have signed a ten-year licensing agreement to develop and commercialize CBD capsules for treating insomnia in Australia.

Avecho and Sandoz Announce Exclusive Ten-Year CBD Partnership for Insomnia Treatment in Australia #Australia #Melbourne #CBD #Avecho #Sandoz